AMH Q1 2026 Earnings Significant EPS Surprise Drives Investor Optimism Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline VOYA Q1 2026 Earnings EPS Surpasses Estimates by 8 Amid Solid Underwriting and Fee Income ADMA Biologics Q1 2026 Earnings EPS Misses Estimates Amid Stock Downdraft PRTH Q1 2026 Earnings EPS Beats Estimates by 277 Stock Rises PRVA Q1 2026 Earnings Profit Miss Overshadowed by Slight Stock Gain